vi But while recognition has increased, the evidence base to support beneficial changes in practice is still growing and will require strong and cohesive calls for change to ensure that such changes are implemented. Thus the new chapter on advocacy in this edition, exploring key components of driving change, the critical participants of successful efforts, and the different paths that progress has been taken internationally.
Thanks to the passion and dedication of many AYA champions around the world, we have come far. And while we still have a long way to go before AYA patients have their own clearly defined, evidence-based care path, I look forward to seeing the progress that will be achieved by the time a 3rd edition hits the press. Heidi Adams President and CEO, Critical Mass: The Young Adult Cancer Alliance, Austin, Texas, USA 
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Despite the remarkable progress made in the treatment of cancer in the pediatric population, cancer remains the leading cause of death from disease in children in the United States. Five-year event free survival exceeds 80 % for many but not all childhood cancers, and late effects are an ongoing challenge for a large number of survivors. Moreover, this progress has not been shared equally across the pediatric-young adult realm, with progress in improving the outcome for adolescents and young adults with cancer too frequently lagging behind advances in other age groups. A number of factors contribute to this, including the lower participation of older adolescents and young adults in clinical trials.
The 1st edition of this textbook highlighted efforts aimed at addressing the scope of the problem of adolescent and young adult under-representation in clinical trials and offered evidence that such a discrepancy may partially explain outcome differences. Chapters presented information about biologic differences between specific cancer subtypes most common in younger children and those exhibited by the same cancers in adolescents and young adults and offered insight into leading factors that contribute to outcome differences as well as potential treatment strategies.
This 2nd edition updates and expands on the work of the original text. Notably, the focus now spans the 15-39 year range, an age group specified by the 2005 Progress Review Group of Adolescent and Young (AYA) Oncology. In these updated chapters, new concepts are presented and data summarized to help bridge our gaps in knowledge. The presenting symptoms and signs, diagnosis, staging, treatment, and late effects are reviewed for each of the common malignancies, together with the epidemiology and risk factors. Principles and practices of care for adolescent and young adult patients with cancer are then discussed, with separate chapters covering specialized units, adherence/compliance, psychological support and related issues, quality of life outcomes, rehabilitation and exercise, late effects, ethical issues, access to care after therapy, future health, resources for survivors, and financial considerations. There are also chapters on access to care before and during therapy, clinical trials, future challenges and opportunities, and international perspectives.
The epidemiology portions use both the International Classification of Childhood Cancer (ICCC) and the International Classification of DiseasesOncology (ICD-O) because cancers occurring in this age group span the pediatric-to-adult spectrum of diseases. This book will help educate medical Foreword viii providers and the public about cancer incidence and survival in this age group and provide impetus for further research to improve the survival and the quality of life of these young people.
The Children's Oncology Group (COG), a National Cancer Institute (NCI)-supported clinical trial group, is the world's largest organization devoted exclusively to childhood and adolescent cancer research. The COG unites more than 9,000 experts in childhood cancer at more than 200 leading children's hospitals, universities, and cancer centers around the world. With the advent of the NCI's new National Clinical Trials Network (NCTN), of which COG is the single pediatric focused group alongside four network groups focused on cancers of the adult population, our hope is that, by increasing research studies designed specifically for the AYA population, the current gap in outcome will begin to close. To this end, we look forward to increased enrollment of AYA patients with cancer onto clinical trials, an overarching goal of the current edition of this book. Until recently, little attention and few resources were devoted to studying the incidence, biology, and treatment outcomes in this age group. With the ability to gather data specific to this age group, the National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) program allows us to estimate that, in the year 2015, there will be between 86,840 and 87,470 new cases of cancer among 15-to 39-year-olds in the United States, including between 71,030 and 71,540 cases of invasive cancer. Compared to the estimated 11,900 cases of all cancer diagnosed in children younger than 15 years of age, the cancer incidence rate in 15-to 39-year-olds is 7.5-fold greater.
With the establishment of the Adolescent and Young Adult Committee of the NCI-funded Children's Oncology Group (COG) in 2000 and with support from the Aflac Foundation, an organized program in research and education for and about young people with cancer has been initiated. I first heard of this initiative in 1996 when I was Chair of the Cooperative Group Chairs.
In 2005, the NCI conducted an evaluation of the issues facing older adolescents and young adults with cancer. Known as a Progress Review Group, this effort was co-sponsored by the NCI and the LIVESTRONG Foundation, and its impact continues to be implemented by the COG, the Critical Mass Young Adult Cancer Alliance, and other national and international organizations. The mission is to identify and prioritize the scientific, medical, and psychosocial barriers facing adolescent and young adult cancer patients and to develop strategies to improve their outcomes. I have had the privilege to co-Chair, along with Drs. Barry Anderson and Archie Bleyer, the Clinical Trials/Research Subcommittee of the Program Review Group that has partially achieved its goal to increase the participation of young adults and older adolescents in clinical trials.
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In 2013, the cooperative groups established the "Intergroup AYA Oncology-NCTN Task Force" and invited representatives from each of the NCTN cooperative groups. This Intergroup effort has now had two face-toface meetings and will assume responsibility for advancing a collaborative program of research for Adolescents and Young Adults across the NCI NCTN (National Clinical Trials Network).
This comprehensive treatise on cancer in adolescents and young adults, edited by Bleyer, and Colleagues, has helped enable the mission of the Program Review Group. It reviews the presenting symptoms and signs, diagnosis, staging, treatment, and late effects for each of the common malignancies in the age group. It would not have been possible without the support of the cooperative group enterprise in the United States or without the extensive data collection efforts of the NCI's SEER program.
I congratulate the editors and authors on the second edition and look forward to continued successful impact of the book and national initiative.
Robert Comis, MD Co-chair, ECOG-ACRIN Cancer Research Group, and President and Chairman, Coalition of Cancer Cooperative Groups (CCCG), Philadelphia, Pennsylvania, USA For the past 25 years, the Teenage Cancer Trust has shown the spotlight on the additional disadvantages experienced by teenage and young adult cancer patients.
As a Founder of the Charity, I have been proud to work both within the United Kingdom and worldwide to redress the dearth of focus experienced by young cancer patients in regard to clinical trials and other research, resources, specialist psychological services, rehabilitation, and particular cancers among other issues. Within the United Kingdom, this formerly neglected cohort of cancer patients has now been recognized not only at the clinical level but also by government. We now see this recognition repeated elsewhere in the world, and the publication of the second edition of Cancer in Adolescents and Young Adults is an example of the enhanced awareness of the problems of the coincidence of youth and cancer.
Many of those contributing to the first edition and also to this edition have been the flag bearers to put young people with cancer on the map-not the least of which are Archie Bleyer and Ronnie Barr who have proved to be motivating voices in the field and originated the 1st edition.
This edition not only updates the original but extends the scope, bringing in new and respected voices from those dedicated practitioners in many fields who have embraced the message promoted by Teenage Cancer Trust many years ago. It will make a valuable contribution to the pool of knowledge and experience put forward by Teenage Cancer Trust's International Conferences and prove to be an essential tool in the fight to improve outcomes in this very sensitive and complex group of cancer patients.
The issues addressed are wide ranging and will be of great assistance to those working in the field seeking to increase clinical trial involvement and improvement in outcomes currently experienced by other cancer groups but not correspondingly by young people. This edition embraces a wider field, in regard to age, topics, authors, and editors, and so offers increased expertise to its readers. 
The Evolution of Adolescent Oncology in the United States Background
Although the history of adolescent and young adult (AYA) oncology is relatively recent, there is evidence that cancer in AYAs precedes and transcends written human history [1] [2] [3] . One of the earliest cases of cancer in an AYA was found by Louis Leakey in 1932 in the remains of either a Homo erectus or an Australopithecus and was suggestive of a Burkitt lymphoma. Osteosarcoma, which has its peak occurrence in the second decade of life, has been found in Egyptian mummies estimated to be AYAs. A case of possible osteosarcoma was also discovered in the mummified skeletal remains of a Peruvian Inca. Centuries, if not millennia later, and late in the history of modern medicine, AYA oncology was born. This review of the recent history, after decades to millennia of omission, describes the major events and rationale that led to the AYA oncology discipline beginning with adolescent oncology. From time immemorial, adolescents have been criticized for their behavior. Socrates complained that "children today are tyrants; they contradict their parents, gobble their food, and tyrannize their teachers." Homer declared "thou knowst the over-eager vehemence of youth, how quick in temper, and in judgment weak." Shakespeare suggested that teenagers be put into suspended animation until of age [4] . Ambivalence, rebellion, desire for freedom from family, conflicts with parents, reaction with intensity, identification with their peers, and sexual activities are archetypal of this age group. An imbalanced rate of demands for privileges and acceptance of responsibility, coupled with the desire to be autonomous and different, has led to antipathy and dislike of adolescent behaviors. Yet these characteristics may be appropriate for this age group and likely constitute one of the pillars of human advancements over the ages.
For adolescents, the transition from childhood to adult status is both difficult and stressful. As such, many experience ambivalence and physical and emotional turmoil, which threaten their ability to become healthy and productive adults. Cancer, a catastrophic, life-threatening disease, has major physical, functional, psychological, and social implications, which are amplified in the AYA age group. While cancer in AYAs is not rare, it poses a Preface xiv sufficiently distinctive challenge to require specialized services [5] . In the 1970s, when cancer was becoming a more "chronic" disease and promising reports of successful treatment in several types of cancer, which heretofore were deemed incurable, appeared in the literature, physicians began treating their patients with curative rather than palliative intent [6] . At that point, it became apparent that a catastrophic disease with uncertain outcome requiring intensive therapy is difficult to face without a major social support system [7] . It had been recognized for some time that care for AYA patients demands an understanding of the process of physical, mental, psychological, and social growth and development [8] . Adolescent services had been in existence in the United States since 1951, when Dr. J. Roswell Gallagher established a unit for adolescent medicine at Boston Children's Hospital [9] .
A Decade of Experience: 1978-1989
Against this background, the first adolescent oncology unit, where one of the authors (CKT) was the director, was established in 1978. This was enabled by a grant from the National Cancer Institute (NCI). The unit was founded through the efforts and support of Dr. James Wallace, the then director of the Division of Cancer Control and Rehabilitation, and the endorsement of Dr. Gerald Murphy, the then Institute Director at Roswell Park Memorial Institute. While adolescent medicine as an entity was not new, the idea of a separate unit for adolescent cancer patients was unique. Establishment of a unit dedicated specifically to cancer was received enthusiastically by patients and their families alike. The reception by medical and surgical subspecialists was far less enthusiastic. There was considerable opposition, expressed and implied, by various medical and surgical services. The ten-bed unit, which was located in a separate building and connected to the main hospital, was resented by most departments on several principles. Most medical and surgical staff physicians preferred their patients to be hospitalized on their own floors. Some were unwilling to lose the adolescent population from their services. Our much more modern facility for adolescents and young adults than the then older hospital floors was also resented. Only with the strong support of Dr. Gerald Murphy, the devotion and resilience of the unit staff, and the demand of patients and their families did the unit survive and flourish. Dr. Murphy had personal experience with adolescence in his own biological and adopted children and had considerable knowledge of adolescents' desires and behavior.
The physical structure of the unit, which was designed with the patients' input, proved to be a major draw [10] . The unit was painted with bright colors and geometric designs appealing to AYA patients. It included a sizable patient lounge with bright furniture, a large aquarium, and decorations. An arcadelike recreation room with the latest in electronic games then available, football, air hockey, bumper pool table, jukebox, stereo system, large TV, and musical instruments, drew the patients' friends to visit them in the hospital. An extensive exercise and arts and crafts room, a classroom, and a library with books and magazines appealing to the age group were provided.
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A well-stocked and equipped kitchen with dining room allowed patients and their parents to cook and dine together. There was no dress code. A laundry room was available to patients so that they could wear their own, not the hospital's, clothes. A room designated as a quiet room was furnished for patients and their families who wanted to take some time off and not be disturbed by anyone, including medical personnel. A separate parents' lounge and room to stay when their child was critically ill allowed parents to be involved, but not intrusively. Selection of the staff for the unit was based largely on their desire and ability to work with AYA patients. Primary nursing care proved to be essential for the operation of the unit. Various programs were designed to promote communication and support emotional stability in crisis situations. A teacher visited patients on a daily basis and, through an agreement with a local college, post-secondary education was available. In retrospect, the educational opportunities offered, especially for those less engaged in school prior to the diagnosis of cancer, were an important function of the unit [10] . Among other programs offered were music therapy, group sessions, and career planning. The unit, in those early days, offered a computer for patients' use, which was then unique. With a grant from Poets and Writers Inc., a creative writing program was established. The unit's monthly newsletter, entitled "Now and Then News," often contained excellent articles or poems expressing patients' and staff's feelings and experiences.
Offices of the staff, including the medical director, patient care coordinator, family counselor, and occupational therapist, were in the unit and open to patients and their families and friends. Patients' records were computerized, allowing access, using a series of codes, to the patients' prior admissions and discharge notes. This was probably one of the earliest attempts at computerized medical record keeping. The unit shared a research laboratory and accepted pre-and postdoctoral trainees.
The rules governing the unit, including visiting hours and visitors' age limit and number, were liberal [4] . A monthly family night was hosted for the patients and their families to attend. In-patient field trips decreased the monotony of staying in the hospital. A home and terminal-care program was designed for patients who opted to stay at home at the end of life. An evaluation program periodically examined satisfaction with the various aspects of the unit's operation by the patients, their families, and staff [10, 11] .
Shortly after the establishment of the unit, it became apparent that information regarding care of the adolescent cancer patients was scanty, if not nonexistent. In a series of investigations, the medical and psychological effects of the diagnosis and treatment of cancer in adolescents were probed. Since nowhere are these effects more exaggerated than with loss of a limb and its effect on body image, physical, psychological, and social functioning of the patient, a major effort was placed on these areas of study. These studies described various aspects of the bone tumors [12] [13] [14] and the short-and longterm effects of the amputation on the patients' lives [15] [16] [17] . The research found that, in general, despite all adversities, in the long-term most amputee patients had adjusted to their circumstances and were leading full and productive lives [15, 17] . Other investigations probed the role of social support systems [7, 18] . Evaluation of the pattern of religiosity and locus of control Preface xvi revealed that adolescent cancer patients were not significantly more religious than established norms [19] . However, among younger adolescents, the diagnosis and treatment of cancer may have accelerated the development of internality, which is expected to be associated with increased age [19] .
Early during the experience of the unit, significant noncompliance with self-administered cancer therapy was noted. This led to a series of studies of patients and parents and a means to improve compliance [20] [21] [22] [23] [24] [25] . Since the psychological aspects of the disease play an important role in the care of patients, great emphasis was placed on this aspect of care [11, 26, 27] . Depression had been observed and studied extensively in adult cancer patients, but no systematic evaluation was available for adolescent cancer patients. In a series of studies, the rate of self-reported depression in cancer patients was examined [28] . Issues pertaining to long-term survivors were other venues for early research. With improved survival, the short-and longterm sequelae of cancer and its treatment, the effects on the vocational achievements of the patients, and their function in the workplace were investigated [29, 30] . This disclosed a greater degree of functional deficits in unemployed than in employed cancer survivors and in health, life, and disability insurance issues [29] . Nevertheless, there was no significant relationship between health status and employment. As a whole, former cancer patients had a higher average income compared to a control group and were competitive members in the workplace [29] . The experiences in establishment of a specialized unit, together with the care and nutrition of these patients, were published [8, 30] . Along with annual adolescent oncology conferences, these reports attracted a large number of interested individuals to work and train in the unit. Publication of the first book solely devoted to adolescent oncology [31] increased the awareness of cancer in adolescents and young adults, albeit to a limited extent.
In 1989, when Dr. Gerald Murphy left Roswell Park, the unit, which was then by far the most modern and progressive floor of the hospital, was viewed as an "extravagance" by the new administration. For cost-cutting purposes, it was decided that its resources should be shared with pediatrics. Consequently, in October of 1989, despite the pleas of dedicated staff and patients, the unit was merged with pediatrics and the AYA cancer program was effectively closed.
Scaling Up: 1992-The Present
A new chapter in AYA oncology commenced when, in October 1992, the American Cancer Society (ACS) sponsored a workshop on Adolescents and Young Adults with Cancer [32]. The conference served as a watershed for recognition of the special needs of this group of patients. It was attended by, and had the support of, Dr. Gerald P. Murphy who, after leaving Roswell Park Cancer Institute and State University of New York, had accepted a position as the chief medical officer of the ACS. To organize this conference was a departure from prior attitudes toward the importance of specialized care for AYA cancer patients. Before the leadership of Dr. Murphy, when an earlier conferPreface xvii ence, entitled "Advances in Care of the Child with Cancer," was being planned by the ACS in 1985, the first author (CKT) suggested that the subject of adolescent oncology be included in the agenda. The organizer of that conference indicated that nothing was new or important enough in adolescent oncology to merit a session, and the subject was declined. The 1992 "Adolescent and Young Adult Conference" was attended by many leaders in pediatrics, adolescent medicine, and medical and surgical oncology, including the chairs of the major pediatric cancer groups. The workshops included sessions on long-term care and lifetime follow-up [33] , insurance and employability [34] , psychological and emotional issues, specialized support groups and compliance [35] , and clinical research implications [36] . The published proceedings of the conference had an important conclusion, which recognized cancer as a significant health problem in the AYA population [32] . It observed that the incidence rate of cancer in patients 15-19 years of age is equal to that of 0-4-year-olds and 1.6 times that in patients between 5 and 14 years of age [37, 38] . The report also brought attention to the relatively infrequent participation of AYAs in clinical trials and ignited initiatives to include AYAs in these endeavors [38] [39] [40] [41] . The 1992 conference also emphasized the necessity for long-term followup and psychosocial support and called attention to discrimination in insurance and employment [37] . The concluding remarks included recommendations to remedy these concerns [37] .
In 1996, the first report on the relative lack of progress in improving survival in adolescents with cancer was published [42] . In 1997, the relative lack of adolescents with cancer on clinical trials compared with children was reported [43] . These observations led the then Chair of the Children's Cancer Group (author AB) to form a task force within the group to research the problem, which led to the appointment, in 1998, of the first AYA Committee in the national cooperative group program of the US NCI. The concept was included for the first time in an NCI Cooperative Group Chair's Competitive Renewal Application, presented at a Site Visit in 1998, and funded with an Outstanding to Excellent score rating.
In 1999, the first NCI Workshop was convened by Malcolm Smith, MD, PhD, and author AB to assess how to increase clinical trial participation by AYA cancer patients. Twenty-eight attendees included chairs and other leaders of the NCI cooperative groups, surgeons, radiation oncologists, medical oncologists, and other specialists in the common cancers in AYAs, as well as ten NCI leaders and a health insurance industry representative.
The genesis of the Children's Cancer Group AYA Committee and the NCI Workshop were harbingers of the fact that there are currently approximately 37 million individuals between the ages of 10 and 19 years living in the United States and, based on SEER and other data, the incidence of cancer in 15-to 19-year-olds was on the rise [39, [43] [44] [45] [46] [47] . In the United States, this increased an average of 0.7 % per year from 1975 to 1997 [40] , yet no agedefined health-care system or providers were generally available to the majority of adolescents [48] . On the other hand, in the United States, the mortality from cancer in the age group decreased at the rate of 3.3 % per year for the period 1965-1974 and 2.6 % per year for the period 1975-1984. Thus, the health care of this group of patients was considered fragmented, in the United States and elsewhere, between medical, pediatric, and general practitioners and others [49] .
In 2000, the four major national pediatric cancer cooperative group organizations (Children's Cancer Group, Pediatric Oncology Group, National Wilms' Tumor Study Group, and Intergroup Rhabdomyosarcoma Study Group) merged into a single national group called the Children's Oncology Group (COG). With this coalescence, an expanded AYA Committee was established to intensify AYA oncology research.
In 2004, the first national philanthropic contribution to AYA oncology research occurred with a grant from the Aflac Foundation to the COG for research by its AYA Committee. The total contribution since then by the Aflac Foundation exceeds US$1.5M. In 2005-2006, the NCI and Livestrong Foundation sponsored the Progress Review Group (PRG) on AYA Oncology [50] that was attended by 97 representatives of the scientific, health care, advocacy, and health insurance organizations. A strategic plan based on the PRG was developed by the Livestrong Young Adult Alliance [51] .
The PRG was a sentinel event in the evolution of AYA oncology, subsequent to which much of what has occurred nationally and internationally has been derived. It has been described as the most (albeit the last) productive of the series of PRGs held by the NCI.
The COG AYA Committee took steps to organize a comprehensive program including subcommittees for all major categories of oncological disorders common among AYA patients. The committee now consists of more than 120 members who represent nearly 20 disciplines and is sustained by funding from the NCI and the health insurance industry. It is organized into five Strategy Groups (disease-specific clinical trials, behavioral oncology, health services research, epidemiology, and awareness) and a sentinel task force on survivorship transition. In addition, the committee has established task forces on access to clinical trials and care, cancer control and community oncology programs, adolescent treatment adherence, exercise and adventure therapy, and development of an informative website.
Unfortunately, years after the demonstration of the benefits of treatment of adolescent patients in a unit of their own [10, 52] , only a handful of specialized adolescent oncology services in the United States are operational. In the United Kingdom, the Teenage Cancer Trust (TCT) is an advocate of these units [53] . There are currently 27 operational units, and there are plans for the establishment of a TCT unit in every regional cancer center. Adolescent oncology units can provide an environment where the age-appropriate atmosphere and facilities, coupled with medical, technological, and psychosocial expertise, can provide specialized care while reducing dropouts from the treatment as well as short-and long-term side effects of cancer and its therapy. In an inquiry sent to 238 COG institutions in the United States, of the 196 that responded, only one hospital had a formal designated adolescent oncology unit (unpublished observation, CKT 2004). In the same inquiry, ten admitted their patients to a general adolescent unit, and only seven had staff who identified specifically with the care of these patients. While adolescents are generally resilient [54, 55] , in adult units these patients are frightened by Preface xix the generation gap, adults disfigured by cancer, and rigid rules imposed upon them while they are hospitalized. Medical oncologists tend to regard 16-to 21-year-olds as adults and do not make a distinction between them and older patients [56] . Furthermore, diagnoses common in older adults are rare in adolescents and young adults [56] . While disputed, at least for some oncological diseases, the treatment of adolescents according to a pediatric protocol has yielded better results than medical oncology protocols [5, [57] [58] [59] . In a pediatric setting, however, AYAs are often demeaned by an atmosphere created for very young children and the childlike manner with which they are often dealt, not considering their age and accomplishments. The patients are often bypassed by the pediatric staff, who habitually communicate with their parents rather than interact directly with the patient.
The history of the development of adolescent oncology would be incomplete if one were remiss in failing to mention the developments in psychosocial and long-term care of the patients [60] . With increased survival, the problems concerning quality of life have gained prominence. Subjects such as "psychological aspects of cancer survivors," "late effects," "long-term survivors clinics," "second cancer," and "transition to adult care," which did not exist before, found their way into the lexicon of oncologists in the United States and elsewhere [61] [62] [63] [64] [65] [66] . Likewise, with significant societal changes in the 1970s and 1980s, the subject of death and dying, which once was "taboo," is discussed openly and has become a new area for research and open discussion. Hospice care, introduced initially by physician Dame Cicely Saunders in the United Kingdom in the early 1960s and culminating with the opening of the first hospice in 1967, has found its way to the United States and has become a part of end-of-life patient care. The American Academy of Hospice and Palliative Medicine, originally chartered as the Academy of Hospice Physicians, was established in 1988 [67] . Publication of 500 interviews with dying patients entitled "On Death and Dying" and analysis by Dr. Elisabeth Kubler-Ross [68] catalyzed a more open discussion with dying individuals, including AYA patients. The trend continues with most major adult and pediatric cancer study groups having established committees on end-of-life care.
Important recent developments in the United States include the publication of guidelines on AYA oncology by the National Comprehensive Cancer Network [69] and the formation of an AYA working group within the National Clinical Trials Network. Corresponding initiatives have been undertaken elsewhere in the world, as in the United Kingdom [70] .
The evolution of AYA oncology in the United States and other parts of the world formed the stimulus to prepare a second edition of Cancer in Adolescents and Young Adults. Assembling a large group of authors from many disciplines has enabled the editors to take advantage of international expertise and experience and address a comprehensive compendium of topics across the spectrum of AYA oncology.
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